Five NCEs Approved In China In 2011: A Closer Look At SFDA’s Progress Report
This article was originally published in PharmAsia News
Executive Summary
China’s SFDA recently released its third annual drug registration report. The agency approved 718 drugs and APIs in 2011, including five NCEs.